IP Library Assignment 045498/0388
Patent Assignment
Reel/Frame 045498/0388

Corrective Assignment to Correct the Assignment Execution Date for Brian W. Metcalf from 08/02/2013 to 08/29/2013 Previously Recorded on Reel 043221 Frame 0344. Assignor(S) Hereby Confirms the Assignment.

Recorded: 2018-03-05 Pages: 8
Assignors
METCALF, BRIAN W.
Executed: 2013-08-29
HARRIS, JASON R.
Executed: 2013-08-29
LI, ZHE
Executed: 2013-08-29
GWALTNEY, STEPHEN L., II
Executed: 2013-08-29
Assignee
GLOBAL BLOOD THERAPEUTICS, INC.
171 OYSTER POINT BLVD., SUITE 300, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Property (1)
Compounds and Uses Thereof for the Modulation of Hemoglobin
Patent: 9,957,250 →
Application: 14/980,890 →
Publication: US 2016/0332984
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 7, 2017
From: METCALF, BRIAN W.; HARRIS, JASON R.; LI, ZHE; GWALTNEY, STEPHEN L., II
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 043221/0344 →
Security Interest Dec 20, 2019
From: GLOBAL BLOOD THERAPEUTICS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 051396/0312 →
Amended and Restated Patent Security Agreement Dec 9, 2020
From: GLOBAL BLOOD THERAPEUTICS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 054664/0871 →
Second Amended and Restated Patent Security Agreement Dec 22, 2021
From: GLOBAL BLOOD THERAPEUTICS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 058575/0921 →
Release of Security Interest Oct 6, 2022
From: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 061620/0186 →